Cargando…

Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy

PURPOSE: Locally advanced esophageal cancers are generally treated with neoadjuvant chemoradiotherapy, followed by surgery in operable candidates. However, even if the patients were diagnosed as operable disease, surgery could not be performed on patients with poor condition or other comorbidity. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dae-Eun, Kim, Uh-Jin, Choi, Won-Young, Kim, Mi-Young, Kim, Seung-Hun, Kim, Min-Jee, Shim, Hyun-Jeong, Hwang, Jun-Eul, Bae, Woo-Kyun, Chung, Ik-Joo, Nam, Taek-Keun, Na, Kook-Joo, Cho, Sang-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893325/ https://www.ncbi.nlm.nih.gov/pubmed/24454000 http://dx.doi.org/10.4143/crt.2013.45.4.276

Ejemplares similares

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
por: Shim, Hyun-Jeong, et al.
Publicado: (2016)

VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma
por: Yoon, Mee Sun, et al.
Publicado: (2011)

Prognostic Significance of Interim Response Evaluation during Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Yeom, Jun Gi, et al.
Publicado: (2021)

Intravenous KITENIN shRNA Injection Suppresses Hepatic Metastasis and Recurrence of Colon Cancer in an Orthotopic Mouse Model
por: Hwang, Jun-Eul, et al.
Publicado: (2011)

Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
por: Bang, Hyun Jin, et al.
Publicado: (2023)

Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study
por: Lee, Soo Jung, et al.
Publicado: (2009)

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017)

Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
por: Kim, Yong-Hyub, et al.
Publicado: (2015)

Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide Exposure
por: Kim, Young Il, et al.
Publicado: (2010)

First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
por: HWANG, JUN-EUL, et al.
Publicado: (2012)

Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
por: Jeong, Hyehyun, et al.
Publicado: (2021)

Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma
por: Yagi, Koichi, et al.
Publicado: (2021)

Complete biologic response to taxane based chemotherapy confirmed by [(18)F]FDG PET/CT and surgery in a cancer of unknown primary site
por: Hwang, Jun-Eul, et al.
Publicado: (2012)

Definitive Chemoradiotherapy versus Radical Hysterectomy Followed by Tailored Adjuvant Therapy in Women with Early-Stage Cervical Cancer Presenting with Pelvic Lymph Node Metastasis on Pretreatment Evaluation: A Propensity Score Matching Analysis
por: Park, Jongmoo, et al.
Publicado: (2021)

Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma
por: Luo, Li-Ling, et al.
Publicado: (2017)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Long term complications and prognostic factors in locally advanced nasopharyngeal carcinoma treated with docetaxel, cisplatin, 5-fluorouracil induction chemotherapy followed by concurrent chemoradiotherapy: A retrospective cohort study
por: Shim, Hyun Jeong, et al.
Publicado: (2020)

FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition
por: Cho, Sang Hee, et al.
Publicado: (2017)

A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting
por: Kim, Ka-Rham, et al.
Publicado: (2015)

An Unusual Case of Submucosal Invasion of Esophageal Squamous Cell Carcinoma Mistaken as Primary Achalasia
por: Park, Jung Ho, et al.
Publicado: (2010)

The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
por: Park, Seong Yong, et al.
Publicado: (2023)

Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy
por: Park, Young Joo, et al.
Publicado: (2010)

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor
por: Hwang, Jun-Eul, et al.
Publicado: (2010)

Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Lee, Nam Kwon, et al.
Publicado: (2014)

A Case of Esophageal Squamous Cell Carcinoma in situ Arising from Esophageal Squamous Papilloma
por: Cho, Jae Yeong, et al.
Publicado: (2019)

Geriatric functional assessment for decision-making on adjuvant chemotherapy in older colon cancer patients
por: Bang, Hyun Jin, et al.
Publicado: (2022)

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2014)

Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer
por: Wu, Sheng-Xi, et al.
Publicado: (2017)

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2011)

Endoscopic Submucosal Dissection Followed by Concurrent Chemoradiotherapy in Patients with Early Esophageal Cancer with a High Risk of Lymph Node Metastasis
por: Kim, Hee Kyung, et al.
Publicado: (2019)

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
por: Cho, Byoung Chul, et al.
Publicado: (2008)

The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
por: Park, Seong Yong, et al.
Publicado: (2020)

Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer
por: Kim, Jun Won, et al.
Publicado: (2016)

Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
por: Chang, Yi-Lin, et al.
Publicado: (2022)

Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
por: Chen, Chih-Yi, et al.
Publicado: (2018)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
por: Chen, Mingqiu, et al.
Publicado: (2018)

FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy
por: Iwabu, Jun, et al.
Publicado: (2019)

Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma
por: Ochi, Masanori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i3mg9m7c3avn9ko473d0cppjdh